Skip to main content
OpenTrials
Completed

NCT Number: NCT04552119

Safety of Treatment of Shoulder Repair

This study evaluates the safety of the HEALICOIL Knotless Suture Anchors in patients requiring a repair of the rotator cuff tendon repair

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Stanford, Redwood City, California, United States

Loading trial locations.

About this study

This is a multicenter, prospective, post-marketing, observational, case series study to evaluate the safety and efficacy of the HEALICOIL Knotless Suture Anchors in subjects with either rotator cuff repair and/or biceps tenodesis. Approximately 160 subjects will be enrolled at up to 6 sites. Safety monitoring will include documentation device- and surgery-related AEs. Efficacy will be monitored by assessment of post-operative follow up, clinical complications, reoperation rate, EQ-5D-5L, and pain VAS.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Requires reattachment of soft tissue to bone for the following shoulder indications:
  • Rotator Cuff Tendon repair:
  • i. Single or double row rotator cuff repair using HEALICOIL Knotless PEEK NST, HEALICOIL Knotless PEEK Self-Tapping, or HEALICOIL Knotless RG Self-Tapping; OR
  • ii. Double row rotator cuff repair using HEALICOIL Knotless RG NST in lateral row (existing HEALICOIL RG device to be used in medial row of the repair); AND/OR
  • Biceps tenodesis
  • i. In conjunction with Rotator Cuff Tendon repair using HEALICOIL Knotless PEEK NST, HEALICOIL Knotless PEEK Self-Tapping, HEALICOIL Knotless RG NST or HEALICOIL Knotless RG Self-Tapping OR
  • ii. As a stand-alone procedure for HEALICOIL Knotless PEEK NST, HEALICOIL Knotless PEEK Self-Tapping, or HEALICOIL Knotless RG Self-Tapping (not HEALICOIL Knotless RG NST
  • Has a pre-operative MRI collected within 6 months of surgery which meets one of the following criteria:
  • MRI collected as standard-of-care has been submitted to external imaging vendor and confirmed as acceptable OR
  • If standard-of-care images are unavailable or considered unacceptable by external imaging vendor, subject must undergo an additional study-specific pre- operative MRI, confirmed as acceptable by external imaging vendor OR
  • MRI not required; subject not in HEALICOIL Knotless RG NST subgroup
  • Has consented to participate in the study by signing the IRB/IEC approved informed consent form.
  • Requires only one variant of the HEALICOIL Knotless Suture Anchor
  • Is ≥18 years of age at time of surgery
  • Willing and able to make all required study visits
  • Able to follow instructions (Approved translated documents supplied upon request)

Exclusion criteria

Any one (1) of the following criteria will disqualify a potential subject from participation in the study:

  • Known hypersensitivity to the implant material. Where material sensitivity is suspected, appropriate tests should be made and sensitivity ruled out prior to implantation.
  • Pathological conditions of bone, such as cystic changes or severe osteopenia, which would compromise secure anchor fixation.
  • Pathological conditions in the soft tissues to be attached that would impair secure fixation by suture.
  • Comminuted bone surface, which would compromise secure anchor fixation.
  • Physical conditions which would eliminate, or tend to eliminate, adequate anchor support or retard healing
  • The presence of infection.
  • Conditions which would limit the subject's ability or willingness to restrict activities or follow directions during the healing period.
  • Concurrent bilateral surgery.
  • Participation in the treatment period of another clinical trial within thirty (30) days of Visit 1, or during the study.
  • Women who are pregnant.
  • Prior ipsilateral surgeries performed on the joint space.
  • Subjects with a medical or physical condition that, in the opinion of the Investigator, would preclude safe subject participation in the study.

Treatment and study plan

HEALICOIL Knotless PEEK

Device

HEALICOIL Knotless PEEK Self-Tapping HEALICOIL Knotless Non-Self Tapping

HEALICOIL Knotless REGENESORB

Device

HEALICOIL Knotless REGENESORB Self -Tapping HEALICOIL Knotless REGENSORB Non-Self Tapping

Primary outcomes

  1. Clinical Success Rate at 6 Months

    Time frame: 6 months

    Clinical success was identified by the repair failure rate defined as the need for a second repair procedure. The second repair procedure would be a repair of the original rotator cuff and/or biceps tenodesis from the index procedure.

Secondary outcomes

  1. Clinical Success Rate at 12 Months

    Time frame: 12 months

    Clinical success identified by the repair failure rate was defined as the need for a second repair procedure. The second repair procedure would be a repair of the original rotator cuff and/or biceps tenodesis from the index procedure.

  2. Clinical Success Rate at 24 Months (HEALICOIL Knotless REGENESORB Non-Self Tapping Suture Anchor ONLY)

    Time frame: 24 months

    Clinical success identified by the repair failure rate was defined as the need for a second repair procedure. The second repair procedure would be a repair of the original rotator cuff and/or biceps tenodesis from the index procedure.

  3. Constant-Murley Score

    Time frame: Baseline, 6 months, 12 months, and 24 months

    Constant-Murley Shoulder (CMS) scale assesses four aspects related to shoulder pathology across four domains of pain, activities of daily living (ADL), range of motion (ROM), and strength. Pain and ADL are answered by the participant. ROM and strength require a physical evaluation and are answered by the surgeon or the physiotherapist. Scores range from 0 to 100, with a higher score indicating better shoulder function (i.e., a better outcome).

  4. American Shoulder and Elbow Surgeons (ASES) Score

    Time frame: Baseline, 6 months, 12 months, and 24 months

    The ASES instrument is composed of 2 sections containing participant self-reported and clinician assessments. It is based solely on participant responses and is a combination of the participant's shoulder pain rating (VAS Pain) and self-reported ability to perform 10 different activities of daily living (ADLs). The ASES score ranges from 0 to 100 with a higher score indicating improvement in pain and function (i.e., a better outcome).

  5. American Shoulder and Elbow Surgeons (ASES): Visual Analog Scale (VAS) Pain Score

    Time frame: Baseline, 6 months, 12 months, and 24 months

    The ASES instrument is composed of 2 sections containing participant self-reported and clinician assessments. It is based solely on participant responses and is a combination of the participant's shoulder pain rating (VAS Pain) and self-reported ability to perform 10 different activities of daily living (ADLs). The ASES VAS Pain score ranges from 0 to 10, where 0 represented no pain and 10 represented the worst pain (i.e., a lower score is a better outcome).

  6. Single Assessment Numeric Evaluation (SANE) Shoulder Scale at 6 Months and 12 Months

    Time frame: Baseline, 6 months, 12 months, and 24 months

    The SANE is a simple, single-question, patient-based shoulder function assessment tool based on responses to the question ''How would you rate your shoulder today as a percentage of normal (0% to 100% scale with 100% being normal)?'' Scores ranged from 0 to 100, where 100 was considered normal (i.e., a better outcome).

  7. EuroQol (European Quality of Life) Five-dimensional Three-level (EQ-5D-3L): Index Score

    Time frame: Baseline, 6 months, 12 months, and 24 months

    The EuroQol EQ-5D-3L is composed of a descriptive system and EQ Visual Analogue Scale (EQ VAS). The descriptive system measures health-related Quality of Life (QOL) that consists of five dimensions of mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension is scored based on one of the three levels of severity (e.g., no problems, some or moderate problems, extreme problems) to create a combined Index Score. The Index Score is reported on a scale of 0 to 1 with a higher score indicating better health.

  8. EuroQol (European Quality of Life) Five-dimensional Three-level (EQ-5D-3L): Visual Analogue Scale (VAS) Score

    Time frame: Baseline, 6 months, 12 months, and 24 months

    The EuroQol EQ-5D-3L is composed of the descriptive system and EQ Visual Analogue Scale (EQ VAS). The EQ VAS was the participants self-rated health scored on a scale of 0 to 100 with 0 indicating 'the worst health you can imagine' and 100 indicating 'the best health you can imagine' (i.e., a higher score is a better outcome).

  9. Tendon Thickening at 6 Months and 24 Months (HEALICOIL Knotless REGENESORB Non-Self Tapping ONLY)

    Time frame: 6 months and 24 months

    Magnetic Resonance Imaging (MRI) was used to determine tendon thickening in millimeters (mm) for the supraspinatus tendon at the Lateral Anterior, Lateral Posterior, Medial Anterior, and Medial Posterior locations at 6 months and 24 months. Lateral measurements were taken from the lateral end of the supraspinatus tendon, about 5mm to the bony insertion site. Medial measurements considered the medial end of the supraspinatus tendon, about 5mm lateral to the musculotendinous junction.

  10. Tendon Re-tear Status at 6 Months and 24 Months (HEALICOIL Knotless REGENESORB Non-Self Tapping ONLY)

    Time frame: 6 months and 24 months

    Magnetic Resonance Imaging (MRI) was used to determine participant tendon Re-tear Status at 6 months and 24 months. Re-tear Status was categorized as either 'Absent' or 'Present' based on the Re-tear Type assessment. 'Absent' indicated a Re-tear Type graded as 'Intact', 'Low-grade Partial-Thickness Tear', or 'High-grade Partial-Thickness Tear'. 'Present' indicated a Re-tear Type graded as 'Full-Thickness Tear'.

Sponsors and collaborators

Lead sponsor

Smith & Nephew, Inc.

Industry

Registry information

Official study title

Prospective, Multi-Center, Post-Market Clinical Follow-up Study to Evaluate Safety and Performance of the HEALICOIL™ Knotless Suture Anchor in Shoulder Rotator Cuff Tendon Repair

Acronym: HEALICOIL_KNTL

Important dates

Study start
2021
Primary completion
2024
Study completion
2024
First posted
Sep 17, 2020
Registry last updated
Apr 16, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.